Article
Keratinocytes and Activation of TREM-1 Pathway in Cutaneous
Leishmaniasis Lesions
Sara Nunes 1,2 , Mariana Rosa Ampuero 1,2 , Ícaro Bonyek-Silva 1,2 , Reinan Lima 1,2 , Filipe Rocha Lima 1,2 ,
Sérgio Marcos Arruda 1,2 , Ricardo Khouri 1,2 , Pablo Rafael Silveira Oliveira 2 , Aldina Barral 1,2,3 ,
Viviane Sampaio Boaventura 1,2 , Cláudia Ida Brodskyn 1,2,3 and Natalia Machado Tavares 1,2, *
1
2
3
*
Citation: Nunes, S.; Ampuero, M.R.;
Bonyek-Silva, Í.; Lima, R.; Lima, F.R.;
Arruda, S.M.; Khouri, R.; Oliveira,
P.R.S.; Barral, A.; Boaventura, V.S.;
et al. Keratinocytes and Activation of
TREM-1 Pathway in Cutaneous
Leishmaniasis Lesions. Microbiol. Res.
2021, 12, 765–778. https://doi.org/
10.3390/microbiolres12040056
Academic Editor: Sofia Casares
Received: 26 June 2021
Accepted: 26 August 2021
Published: 7 October 2021
Publisher’s Note: MDPI stays neutral
LaIPHE, Oswaldo Cruz Foundation, Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, Bahia, Brazil;
sara_nunes2@hotmail.com (S.N.); mariana.ampuero@hotmail.com (M.R.A.); icaro.bonyek@gmail.com (Í.B.-S.);
reinanlimadeus@hotmail.com (R.L.); rfilipelima@gmail.com (F.R.L.); sergio.arruda@fiocruz.br (S.M.A.);
ricardo_khouri@hotmail.com (R.K.); aldina.barral@fiocruz.br (A.B.); viviane.boaventura@fiocruz.br (V.S.B.);
claudia.brodskyn@fiocruz.br (C.I.B.)
School of Medicine and Institute of Biology (IBIO), Federal University of Bahia,
Salvador 40110-100, Bahia, Brazil; pablorafael_ssa@hotmail.com
Instituto Nacional de Ciência e Tecnologia (INCT) iii—Instituto de investigação em Imunologia,
São Paulo 05401-350, São Paulo, Brazil
Correspondence: natalia.tavares@fiocruz.br
Abstract: Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) amplifies the immune response, operating synergistically with Toll-Like Receptors (TLRs) in the production of inflammatory
mediators. TREM-1 signaling depends on the adapter protein DAP12, which results in the activation
of NFkB, the expression of inflammatory genes, and the release of antimicrobial peptides, such
as Beta-defensin 2. We evaluated the activation of the TREM-1 signaling pathways in Cutaneous
Leishmaniasis (CL) caused by Leishmania braziliensis and linage human keratinocytes exposed to
these parasites since the host immune response against Leishmania plays a critical role in promoting
parasite killing but also participates in inflammation and tissue damage. We analyzed publicly
available transcriptome data from the lesions of CL patients. In the CL biopsies, we found increased
expression of the molecules involved in the TREM-1 pathway. We then validated these findings with
RT-qPCR and immunohistochemistry in newly obtained biopsies. Surprisingly, we found a strong
labeling of TREM-1 in keratinocytes, prompting the hypothesis that increased TREM-1 activation
may be the result of tissue damage. However, increased TREM-1 expression was only seen in human
lineage keratinocytes following parasite stimulation. Moreover, no up-regulation of TREM-1 expression was observed in the skin lesions caused by other non-infectious inflammatory diseases. Together,
these findings indicate that L. braziliensis (Lb) induces the expression of the TREM-1 receptor in tissue
keratinocytes regardless of tissue damage, suggesting that non-immune skin cells may play a role in
the inflammatory response of CL.
Keywords: Leishmania; inflammation; TREM-1; keratinocytes
with regard to jurisdictional claims in
published maps and institutional affiliations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1. Introduction
Leishmaniasis is a complex of neglected tropical diseases caused by a protozoan
parasite of the genus Leishmania. Among them, cutaneous leishmaniasis (CL) is the most
frequent form of the disease. The immune response in cutaneous leishmaniasis caused by
Leishmania braziliensis (Lb) is considered highly inflammatory, which is crucial for parasite
killing but leads to tissue damage [1–4]. CL lesions are chronic skin ulcers with raised
edges and a necrotic center. Its development depends on the Leishmania species in addition
to a combination of factors associated with the host immune response, which defines
different clinical outcomes. Several studies have suggested that the severity of CL is more
associated with an exacerbated inflammatory response than a consequence of parasite
burden. Chronic and exacerbated inflammation of CL has been associated with the high
Microbiol. Res. 2021, 12, 765–778. https://doi.org/10.3390/microbiolres12040056
https://www.mdpi.com/journal/microbiolres
Microbiol. Res. 2021, 12
766
production of pro-inflammatory cytokines and increased expression of pattern recognition
receptors (PRRs), such as TREM-1, which amplify the innate immune response against
pathogens [1,3,5,6].
TREM-1, the triggering receptor expressed in myeloid cells, is an activating receptor
present in neutrophils, monocytes, and macrophages [7]. It is activated during inflammatory and infectious conditions that involve the release of high levels of pro-inflammatory
cytokines and chemokines. TREM-1 signals through the DAP12 adapter protein (DNAX
activation protein of 12 kDa), and it can be cleaved into its soluble form (sTREM-1), which
is crucial to modulate cell signaling [8–10]. TREM-1 expression has been associated with
excessive inflammation and tissue damage rather than pathogen clearance [6]. In this
context, Carneiro and collaborators (2016) [11] have already identified the activation of
the TREM-1 pathway in cells from healthy individuals who are high producers of IFN-γ
in response to L. braziliensis stimulation in vitro. More recently, our group identified the
up-regulation of the TREM-1 pathway and its gene as a potential target for microRNAs
in lesions caused by L. braziliensis associated with a good response to treatment and CL
prognosis [12].
Studies with in vitro and in vivo approaches have investigated the TREM-1 pathway
in leishmaniasis. However, few aspects of TREM-1 expression have been described in the
context of human CL caused by L. braziliensis, especially with respect to the keratinocytes
in the lesions. It has already been demonstrated that human neutrophils infected in vitro
with L. infantum upregulate the expression of TREM-1, DAP-12, and IL-8. In addition,
increased serum levels of the soluble form of TREM-1 (sTREM-1) were associated with the
severity of visceral leishmaniasis (VL) [13]. Neutrophil recruitment to CL lesions has also
been associated with TREM-1 in experimental models. Mice deficient for TREM-1 develop
smaller CL lesions due to a reduced neutrophil infiltrate after L. major infection without
altering the capacity to control the parasite. These studies suggest that TREM-1 could be a
promising target for controlling exacerbated inflammation without interfering in parasite
killing [6].
Regardless of the species, Leishmania infection begins in the skin, and it is crucial to understand the mechanisms involved in the early moments of lesion development. This will
allow the development of new strategies to control exacerbated inflammation and tissue
damage [14,15]. Keratinocytes are the major cell type found in the epidermis, the outermost
layer of the skin [16]. They have been extensively studied in different skin lesions, but few
studies have evaluated the interaction between keratinocytes and Leishmania spp. [5]. It
is known that despite their phagocytic capacity, the interaction between Leishmania and
keratinocytes does not result in significant amounts of internalized parasites [14,17]. In
addition, their ability to proliferate inside the keratinocytes is compromised [14]. Although
these findings do not suggest a close contact between Leishmania and keratinocytes, their
interaction is considered immunomodulatory. The exposure of primary keratinocytes to L.
major or L. infantum induced different responses in each case. A significant production of
pro-inflammatory cytokines was observed in keratinocytes cultured with L. infantum compared to those cultured with L. major [14]. These data suggest that a non-immune cell type
can influence the inflammatory response during Leishmania infection and, consequently,
the disease outcome. However, there is a lack of knowledge regarding the involvement of
the TREM-1 pathway and keratinocytes during L. braziliensis infection, the most prevalent
species in Brazil.
In the present study, we sought to investigate the expression of the TREM-1 pathway
in human CL lesions caused by L. braziliensis and to further localize its expression in the
tissue of newly obtained biopsies. We found that the TREM-1 pathway is broadly activated
in CL at both the gene and protein levels, mostly in the epidermis. The same results were
found in the human adult keratinocyte cell line (Hacat) in vitro after L. braziliensis exposure,
leading us to evaluate other inflammatory skin diseases. Taken together, this is the first
study to localize TREM-1 in the lesions of humans caused by L. braziliensis. Furthermore,
767
Microbiol. Res. 2021, 12
non-infectious inflammatory skin diseases do not modulate TREM-1 expression, suggesting
that L. braziliensis induces the TREM-1 pathway regardless of tissue damage.
2. Materials and Methods
2.1. Transcriptome and Pathway Analysis
The Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/geo/, accessed on 10 May 2017) repository was used to find transcriptome datasets related to
“human biopsies”, “Leishmania braziliensis” and “healthy control”. Two sets of data that
evaluated biopsies from patients with CL compared to healthy controls were found registered under the codes GSE55664 (Illumina HT12 v4 platform) and GSE63931(Agilent Sure
Print GE Human G3v2 platform), which were published by Novais and collaborators [18]
and Oliveira and collaborators [19], respectively. The former dataset compared 25 CL
lesions (8 early and 17 late infections) with 10 healthy skin samples. The later dataset
evaluated 8 CL lesions (recently treated) and 8 healthy skin samples. Ingenuity Pathway
Analysis software (IPA Tool; Ingenuity Systems; http://www.ingenuity.com, accessed on
20 October 2017) was used to evaluate the data and to find the canonical pathways related
with a cutaneous leishmaniasis.
The public GEO repository was later used to search for other transcriptome datasets
for non-infectious inflammatory skin diseases: psoriasis (GSE53431) and systemic lupus
erythematous (SLE) (GSE72535). In the psoriasis data set, 12 CL samples were compared
to 12 healthy skin samples. Regarding the lupus transcriptome, nine CL samples were
compared to nine control skins.
2.2. Analysis of the TREM-1 Signaling Pathways
Expression data were analyzed using the Multi Experiment Viewer (MeV) (www.tm4
.org/mev.html, accessed on 12 May 2017). Differentially expressed genes (DEGs) were
determined based on the differences of variances between the two groups of samples (log2 ).
For the hierarchical cluster analysis, the distance between the samples was determined
by the Euclidean distance and the average link (average-linkage). Heatmaps were used
to represent the expression of the transcript probes through signal strength. Principal
component (PCA) analysis grouped samples based on the expression of genes from the
TREM-1 pathway, where PCA1 and PCA2 corresponded to more than 50% of the data
variability. Volcano plots highlights the differences in the expression of the transcripts in
the CL samples compared to the healthy control skin samples (Fold change (FC) ≥2.0),
with a Benjamini–Hoshberg False Discovery Rate (FDR)-adjusted p-value of <0.05 as a
criterion to identify the DEGs.
2.3. Patients and Ethics Statement
The samples were obtained from 12 active lesions from CL patients from Jiquiriça,
Bahia, Brazil. The diagnostic criteria were based on clinical signs of CL, histological characteristics, and positive response for late hypersensitivity (DTH). Biopsies were collected at
the border of the lesions using a 4-mm punch before treatment. Additionally, seven control
samples were taken from volunteers who were living in a non-endemic area without a
history of leishmaniasis. The study was conducted according to the principles of the
Declaration of Helsinki and under local ethical guidelines. This study was approved by
the Ethical Committee of the Gonçalo Moniz Institute (Salvador, Bahia, Brazil—protocol
number CAAE 42928215.9.0000.0040, approved in 4 July 2015). Informed consent was
obtained from all patients.
2.4. Cell Culture and Infection
HaCaT cells (Lineage human keratinocytes) were cultured in 5% CO2 at 37 ◦ C in regular Dulbecco’s Modified Eagle’s Medium (DMEM—Gibco), supplemented with 10% fetal
bovine serum and 2 mM L-glutamine, 100 U/mL penicillin, and 100 µL/mL streptomycin
768
Microbiol. Res. 2021, 12
(Invitrogen, San Francisco, CA, USA). The cells were seeded at a density of 5 × 105 cells,
plated in 24-well plates, and cultured with for 5 days (70–80% confluency).
Leishmania braziliensis MHOM/BR/01/BA788 were expanded in Schneider medium
(Sigma) supplemented with 20% of fetal bovine serum (FBS) and 1% PSG (2 mM Lglutamine, 100 U/mL penicillin and 100 µL/mL streptomycin). After 5 days of culture,
metacyclic promastigotes in the stationary phase were used. The HaCat cells were exposed
to Leishmania at a 5:1 ratio (parasite: cell) for 4 h. In addition, some cells were subjected to
mechanical lesions (wound healing) performed with a 200 µL tip on the confluent monolayer in order to mimic lesions in these cells and to subsequently evaluate the expression of
the culture. The cultures were washed with saline and were then placed in 700 µL Trizol
(Life technologies, Carlsbad, CA, USA) for RNA extraction (two independent experiments
were performed in triplicate and quadruplicate).
2.5. Quantitative Real Time Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted using the Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocols. The cDNA was generated using the
SuperScript ™ II Reverse Transcriptase Kit (Invitrogen, San Francisco, CA, USA), following the manufacturer’s instructions. Gene expression was evaluated in duplicate on ABI
7500 real-time PCR equipment (Applied Biosystems, Foster City, CA, USA) following the
manufacturer’s instructions. The relative expression was calculated using the comparative
limit cycle (Ct) and was compared to the control (fold change) in addition to normalizing
the reaction with the constitutive gene β-actin. The sequences of the primers are described
in Table 1.
Table 1. Oligonucleotide sequences for primers used in the assay.
Gene
Primer Sequence
TREM1
GAACTCCGAGCTGCAACTAAA (F)
TCTAGCGT GTAGTCACATTTCAC (R)
TYROBP
ACTGAGACCGAGTCGCCTTAT
(F) ATACGGCCTCTGTGTGTTGAG (R)
TLR2
CCTACTGGGTGGAGAACCTTAT (F)
CAGGAATGAAGTCCCGCTTATG (R)
DEFB4A
CGC CTA TAC CAC CAA AAA CAC (F)
TCC TGG TGA AGC TCC CA (R)
ACTB
CCT TGC ACA TGC CGG AG (F)
ACA GAG CCT CGC CTT TG (R)
2.6. Immunohistochemistry
Immunohistochemistry was performed to evaluate the expression of TREM1, Def
β2, DAP12, and TLR2, following the manufacturer’s instructions. Briefly, skin biopsies
(six healthy skin samples and six CL lesions) were fixed with 10% formalin, dehydrated,
and embedded in paraffin. Then, they were deparaffinized and hydrated, and we performed antigenic recovery followed by incubation with monoclonal antibodies anti-TREM1
(Abcam, Cambridge, UK), anti-Def β2 (Biorbyt, Cambridge, UK), anti-Dap12 (Abcam, Cambridge, UK), or anti-TLR2 (Millipore, Billerica, MA, USA) according to the manufacturer’s
instructions. The images were obtained using a Nikon E600 microscope and an Olympus
Q-Color 1 digital camera and were quantified using ImageJ software.
2.7. Statistical Analysis
Statistical analyzes were performed using the GraphPad-Prism 8.0 statistical software.
Comparisons between the two groups were performed using the Mann–Whitney nonparametric test, and analyses with more than two groups were performed using the
769
Microbiol. Res. 2021, 12
Kruskal—Wallis or the Friedman test followed by Dunn’s post test. * p < 0.05, ** p < 0.01,
and *** p < 0.001 were considered statistically significant.
3. Results
3.1. TREM-1 Signaling Pathway Is Significantly Up-Regulated in CL
The transcriptome data (GSE55664 and GSE63931) of the human skin biopsies of
the lesions caused by L. braziliensis were analyzed in order to identify key the pathways
associated with CL. We evaluated the datasets using the “Core analysis” module of the
IPA software to identify the canonical pathways related to the “Innate Immune response”
during CL. The TREM-1 receptor signaling pathways were among the most up-regulated
pathways in both datasets (ranked fourth in both datasets) (Figure 1A,D). To explore
the TREM-1 pathway, volcano plots were constructed based on the whole transcriptome
data genes, and the genes related to the TREM-1 pathway were identified (red dots—
Figure 1B,E). For both datasets, 19 TREM-1 pathway genes were found to be significantly
up-regulated. We further detailed the fold change values for each gene (Figure 1C,F), which
showed a strong correspondence of gene expression between the two datasets. Together,
these results indicate that the TREM-1 pathway is significantly activated in CL lesions.
Figure 1. TREM-1 pathway is up-regulated in the lesions of CL patients. Canonical pathways identified in CL lesions by
Ingenuity Pathway Analysis (IPA) software for the (A) GSE55664 and (B) GSE63931 datasets. Bars represent the number of
genes in a pathway that are present in each data set found up-regulated (yellow) or down-regulated (blue). Volcano plots
show gene expression of the entire (C) GSE55664 and (D) GSE63931 datasets, highlighting the genes from TREM-1 pathway.
Fold change >2 (dashed line) of gene expression from TREM-1 pathway for the (E) GSE55664 and (F) GSE63931 datasets.
770
Microbiol. Res. 2021, 12
3.2. Expression Profile of Genes from the TREM-1 Pathway Distinguishes CL Samples from
Healthy Controls
Next, heatmaps were built to show the gene expression profile of the TREM-1 pathway
for each sample, and hierarchical clustering analyses differentiated the control from the
CL samples for both datasets (Figure 2A,B). We further performed Principal Component
Analysis (PCA) based on data variances that confirmed differential expression of the TREM1 pathway between the controls and the CL samples (Figure 2C,D). These results confirm
the differential regulation of the TREM-1 pathway in the biopsies from the CL lesions
compared to the healthy skin samples.
Figure 2. Differentially expressed genes of the TREM-1 pathway distinguished from the CL and control samples. Heatmaps
of the Euclidean distance method realized by unsupervised hierarchical clustering of CL samples (black) and healthy
controls (grey), showing the expression profile of 19 genes differentially expressed (A,B) and the Principal Component
Analysis (C,D) of GSE55664 and GSE63931 datasets, respectively.
3.3. Validation of Differentially Expressed Genes from TREM-1 Pathway in Active Lesions of CL
Although the expression of TREM-1 and sTREM-1 (soluble form) has been demonstrated during the infection of different Leishmania species, the activation of the TREM-1
pathway in Cl lesions caused by Lb remains undetermined [6,11–13,20]. To validate the
activation of the TREM-1 pathway in CL, some genes were selected based on their role
within the pathway, such as receptors the TREM-1 and TLR2, the adaptor protein DAP12
(coded by TYROBP gene) and the product DEFB4A. We assessed new biopsies from patients with CL caused by Lb to compare the expression of these genes with the healthy skin
Microbiol. Res. 2021, 12
771
samples by means of RT-qPCR. TREM1, TLR2, TYROBP, and DEFB4A were significantly
up-regulated in the CL lesions, considering a p value < 0.05 and a fold change greater
than 2.0 (Figure 3A–D). These results confirm the findings from publicly available datasets
and show that L. braziliensis infection enhances the expression of TREM- 1 and molecules
associated with its activation.
Figure 3. Increased expression of genes from the TREM-1 signaling pathway in CL lesions. Relative
gene expression profile of (A) TREM-1 (n =10), (B) DEFB4A (n = 7), (C) TLR2 (n = 9) and TYROBP
(n = 6), and (D) by RT-qPCR. Data analyzed by the Mann-Whitney t test comparing CL biopsies
(black bars) with healthy controls (grey bars). Bars represent the median ± SEM and * p ≤ 0.05,
≤
≤
*** p ≤ 0.001. HC (healthy control).
3.4. TREM-1 Protein Is Highly Expressed in the Epidermis of CL Lesions from Patients Infected
with L. braziliensis
To evaluate the presence of TREM-1 and other proteins associated with its pathway,
we labeled these molecules in the tissue biopsies from the CL lesions with immunohistochemistry. Corroborating our gene expression results, this approach revealed higher
TREM-1 expression in the epidermis as well as in the inflammatory infiltrate of the CL
lesions when compared to healthy skin samples (Figure 4A). The quantification of the
labeled area indicates that over 50% of the cells in the lesions were immunostained with
TREM-1 (Figure 4B). We further quantified TREM-1 labelling between the epidermis and
the inflammatory infiltrate using an automatized method. The results show 52 positive
cells/mm2 of the epidermis compared to 28 positive cells/mm2 of the inflammatory infiltrate. This estimate suggests that proportionally, keratinocytes are expressing more
TREM-1 than the inflammatory infiltrate, which could play a relevant role in CL lesions.
Similar results were observed for TLR-2, DAP12, and DEFB4A, where increased protein
772
Microbiol. Res. 2021, 12
labeling was shown in the inflammatory infiltrate of CL lesions compared to healthy skin
(Figure 4A,B). These results confirm that the TREM-1 pathway is strongly induced in the
skin affected by L. braziliensis infection and that it may have a key role in the exacerbated
inflammation that characterizes this disease.
Figure 4. Increased protein levels of molecules from the TREM-1 pathway in biopsies from CL lesions caused by Lb infection.
(A) Immunohistochemistry for TREM-1, TLR2, DAP12, and DEFB4A of lesions from CL patients. Long scale bars represent
20 mm. Black rectangles designate region of 400 magnification. (B) Quantification of protein expression from TREM-1
pathway molecules by the Image J software. Representative images of immunohistochemistry label from biopsies of lesions
caused by L. braziliensis compared to healthy skin samples (n = 6). p value < 0.01 ** were considered significant.
773
Microbiol. Res. 2021, 12
3.5. Gene Expression of TREM-1 Is Increased in Keratinocytes Exposed to L. braziliensis but Not to
Mechanical Damage
Considering our findings on TREM-1 pathway activation in CL lesions, we next evaluated its expression and its main genes in human keratinocyte (HaCat) in vitro when
exposed to different inflammatory conditions, such as L. braziliensis or scratch (mechanical/physical damage to cells). Results obtained with this approach indicate that TREM-1
expression is only increased after L. braziliensis exposure (Figure 5A), and no difference is
observed for scratch (Figure 5C). On the other hand, the expression of DEFB4A is increased
for all of the tested conditions: L. braziliensis (Figure 5B), scratch (Figure 5D). These findings
suggest that L. braziliensis infection increases the expression of TREM-1, whereas DEFB4A
modulation seems to be an unspecific result of a pathogen (or its molecules) or cell damage.
Figure 5. Differential TREM-1 and DEFB4A expression by human keratinocytes exposed to L. braziliensis or mechanical
damage (scratch). Lineage human keratinocytes (HaCaT) were exposed to L. braziliensis at a 5:1 ratio (A,B) or scratch
to mimic cell damage in the absence of a pathogen (C,D). After 4 h, the relative expression of TREM-1 (red bars) and
DEFB4A (blue bars) was analyzed by RT-qPCR and is represented as a simulated fold change compared to the unstimulated
(grey bars) cultures. Bars represent median ± standard error of two independent experiments performed in triplicate and
quadruplicate each. The Mann–Whitney t test considered significant p values < 0.05 * and <0.001 ***.
3.6. Overexpression of TREM-1 Is Specific of CL and Is Not Observed in Other Non-Infectious
Inflammatory Skin Diseases
We next compared the expression profiles of TREM-1 and DEFB4A found in L. braziliensis skin lesions with other inflammatory skin diseases in order to evaluate their specificity
for CL. The GEO database was used to search for transcriptome datasets of non-infectious
774
Microbiol. Res. 2021, 12
inflammatory skin diseases. We found two transcriptomes matching these criteria: one from
psoriasis (GSE53431) and the other from systemic lupus erythematous (SLE) (GSE72535).
The expression profile of DEFB4A was found to be significantly increased in all of the evaluated diseases (Figure 6). On the other hand, the expression of TREM-1 was significantly
induced only in samples from patients with CL (GSE55664 and GSE63931). These data
suggest that the expression of defensin DEFB4A is induced in inflammatory skin diseases
regardless of their etiology, and TREM-1 expression appears to be specific for CL.
Figure 6. Activation of TREM-1 signaling is specific to skin lesions affected by L. braziliensis infection. Expression profile
of TREM-1 (crimson bars) and DEFB4A (blue bars) in different inflammatory diseases of the skin analyzed from publicly
transcriptome datasets for psoriasis (GSE53431), lupus (GSE72535), and leishmaniasis (GSE55664 and GSE63931). Fold
change >2 (dashed line) of gene expression.
4. Discussion
TREM-1 has emerged as a key molecule during inflammatory diseases, promoting
complex effects on cells of the immune system and exacerbating the host response [7,8].
Studies have explored the role of TREM-1 in inducing inflammation in multiple contexts,
such as sepsis [9,21], cancer [22], viral infections [23,24], and others non-infectious diseases [25,26]. However, the role of TREM-1 signaling in innate immunity against parasite
infections and its underlying mechanisms remain unknown [13,27,28].
Here, we identified the TREM-1 pathway as an element of the innate immune response
elicited in CL caused by L. braziliensis. The overexpression of TREM-1 and other molecules
of this pathway, such as TYROBP, TLR2 and DEFB4A, were confirmed in new biopsies
from CL patients.
Considering infectious diseases, the activation of the TREM-1 pathway has been more
associated with disease severity than with infection control [6–8]. Studies have shown that
influenza-infected Trem1−/− mice exhibit reduced morbidity but an equal capacity for
viral clearance [6]. Similarly, the infection of Trem1−/− mice with L. major leads to smaller
inflammatory lesions with decreased neutrophilic cellular infiltrates in Trem1−/− mice.
However, the parasite counts did not differ between the groups [6]. In accordance with
this data, another study reported that the TREM-1 signaling pathway is highly activated
by L. major infection in susceptible mice [20]. In addition, studies show that the plasma
levels of sTREM-1 are associated with the severity of malaria in children [26,29]. Regarding
Schistosoma infection, some substances from Schistosoma eggs may inhibit the expression of
TREM-1 on mouse macrophages. This mechanism can decrease the macrophage-mediated
Microbiol. Res. 2021, 12
775
inflammatory response in infected hosts [28]. On the other hand, neutrophils infected by L.
infantum enhance the transcription of TREM-1 and molecules associated with its activation
as well as the release of sTREM-1. Both were associated with clinical parameters of visceral
leishmaniasis severity, suggesting that the release of sTREM-1 inhibits inflammation and
favors disease development by impairing TREM-1 signaling [13].
Despite these findings in several infectious diseases, few studies have investigated
the role of the TREM-1 in L. braziliensis infection, the main etiological agent of CL in
Brazil. A previous report with peripheral blood mononuclear cells from healthy donors
stimulated in vitro with L. braziliensis only found an activated TREM-1 pathway in cells
from producers with high levels of IFN-γ [11]. Moreover, a metanalysis from our group
revealed correlations between TREM-1, miR193b, and miR-671 associated with a good
response to treatment in human CL caused by L. braziliensis [12]. However, the activation
of the pathway has remained unexplored.
In the present study, our immunohistochemical analysis revealed a significant increase
in the expression of TREM-1 and other proteins of its pathway in the biopsies of patients
with CL. Similar results were found in lineage human keratinocytes (HaCats) exposed to L.
braziliensis. However, unlike the exposure to Leishmania, the expression of TREM-1 mRNA
in samples exposed to mechanical damage (scratch) did not show a significant increase of
this molecule. These data suggest that the modulation of TREM-1 expression is strongly
correlated with L. braziliensis infection.
Keratinocytes are the major structural component of the epidermis, but emerging
evidence indicates their role in the immune response [30,31]. These cells express certain
PRRs, including TLRs [32–35], which is an important pathway for Leishmania recognition by
phagocytic cells and parasite internalization [36–38]. It has been shown that keratinocytes
internalize L. major or L. infantum at low levels in vitro [14], but the exact mechanism by
which keratinocytes recognize and phagocyte Leishmania is still unknown. Despite their
inefficient phagocytosis of Leishmania, they robustly respond to parasite exposition [14],
suggesting that surface molecules from Leishmania contribute to keratinocyte activation.
Several molecules are involved in the inflammatory processes associated with TREM-1
signaling, among them, Toll-like receptors, adaptor proteins and defensins. The activation
of TREM-1 is associated with the DAP12 protein, which is encoded by the gene TYROBP
and its ligand, which is still unknown. DAP12 couples to multiple receptors on the cell
surface, and, when combined with TREM-1, contributes to the amplification of the inflammatory response by inducing the production of pro-inflammatory molecules [10,39,40].
Our data show that the expression of TYROBP mRNA and DAP12 protein are significantly
up regulated in samples from CL biopsies, corroborating previously published studies.
The TREM-1 amplified response is also mediated via Toll-like receptors (TLRs), mainly
TLR2 and TLR4. In association with pathogen-associated molecular patterns (PAMPs) and
damage-associated molecular patterns (DAMPs), TREM-1 induces the release of cytokines
and chemokines through the NFκB pathway. In addition, this mechanism may also induce
the release of the antimicrobial peptides present in granulocytes, mainly in mucosal and
cutaneous immune responses, such as in defensins [40–42].
Defensins are a large family of antimicrobial peptides widely that are distributed
in animals and plants. They are considered part of the innate immune response, where
they contribute to the antimicrobial activities of cells, especially granulocytes, developing
functions associated with the prevention and control of infections, autoimmune diseases,
and cancer [41,43,44]. According to previously published studies, our findings show that
after exposure to L. braziliensis, the expression of DEFB4A significantly increases at both the
transcriptional and protein levels. In addition, defensin response appears to be non-specific
since it was observed in mechanical damage (scratch) and also in non-infectious skin
diseases (psoriasis and lupus).
We further evaluated the specificity of the TREM-1 observed in response to L. braziliensis infection in vitro through the analysis of public transcriptome datasets of non-infectious
inflammatory skin diseases (psoriasis and lupus). In contrast to the CL findings, the
776
Microbiol. Res. 2021, 12
modulation of TREM-1 was not observed in these non-infectious skin diseases. On the
other hand, the expression of DEFB4A is upregulated in all of the evaluated diseases as
well as in response to the different stimulations we tested in vitro. These findings suggest
that the TREM-1 response may be specifically related to the development of CL lesions
and that defensin may be a product of tissue damage, regardless of the disease etiology.
Therefore, this study provides evidence that human keratinocytes are able to strongly
express TREM-1, which highlights the potential of non-immune cells in the inflammatory
response against Leishmania.
Author Contributions: Conceptualization, S.N., M.R.A., Í.B.-S., R.L. and N.M.T.; methodology, S.N.,
M.R.A., Í.B.-S., R.L. and N.M.T.; software, S.N., M.R.A., Í.B.-S., R.L. and N.M.T.; validation, S.N.,
M.R.A., Í.B.-S., R.L. and N.M.T.; formal analysis, S.N., M.R.A., Í.B.-S., R.L., F.R.L., S.M.A., R.K.,
P.R.S.O., A.B., V.S.B., C.I.B. and N.M.T.; investigation, S.N., M.R.A., Í.B.-S., R.L. and N.M.T.; resources,
C.I.B. and N.M.T.; data curation, S.N., M.R.A., Í.B.-S., R.L. and N.M.T.; writing—original draft
preparation, S.N., M.R.A., Í.B.-S., R.L., F.R.L., S.M.A., R.K., P.R.S.O., A.B., V.S.B., C.I.B. and N.M.T.;
writing—review and editing, S.N., M.R.A., Í.B.-S., R.L., F.R.L., S.M.A., R.K., P.R.S.O., A.B., V.S.B.,
C.I.B. and N.M.T.; visualization, S.N., M.R.A., Í.B.-S., R.L., F.R.L., R.K., P.R.S.O., V.S.B., C.I.B. and
N.M.T.; supervision, N.M.T.; project administration, C.I.B. and N.M.T.; funding acquisition, C.I.B.
and N.M.T. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by FAPESB (Fundação de Amparo à Pesquisa do Estado na
Bahia), grant number PET0004/2015 (Edital PROINTER), CAPES (Coordenação de Aperfeiçoamento
de Pessoal de Nível Superior), financial code 001 and CNPq (Conselho Nacional de Desenvolvimento
Científico e Tecnológico).
Institutional Review Board Statement: The study was conducted according to the guidelines of
the Declaration of Helsinki and was approved by the Ethical Committee of the Gonçalo Moniz
Institute—Salvador, Bahia, Brazil (protocol code 42928215.9.0000.0040.
Informed Consent Statement: All participants completed the Informed Consent Statement.
Data Availability Statement: Gene Expression Omnibus (GEO) (https://www.ncbi.nlm.nih.gov/
geo/)—GSE55664 and GSE63931 (accessed on 10 May 2017); GSE53431 and GSE72535 (accessed on 4
December 2017).
Acknowledgments: The authors thank all patients who participated of this study and the professional group that recruited the participants. The authors thank Andrezza Kariny and Isabele
Coelho for secretarial assistance. The authors thank Zaira Onofre from the RT-PCR facility—PDTIS
(FIOCRUZ).
Conflicts of Interest: The authors declare no conflict of interest.
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
Kaye, P.; Scott, P. Leishmaniasis: Complexity at the host-pathogen interface. Nat. Rev. Microbiol. 2011, 9, 604–615. [CrossRef]
WHO Leishmaniasis. Available online: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis (accessed on 5
January 2021).
Scott, P.; Novais, F.O. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat. Rev. Immunol. 2016, 16,
581–592. [CrossRef]
Carvalho, L.P.; Passos, S.; Schriefer, A.; Carvalho, E.M. Protective and pathologic immune responses in human tegumentary
leishmaniasis. Front. Immunol. 2012, 3, 301. [CrossRef] [PubMed]
Scorza, B.M.; Carvalho, E.M.; Wilson, M.E. Cutaneous Manifestations of Human and Murine Leishmaniasis. Int. J. Mol. Sci. 2017,
18, 1296. [CrossRef] [PubMed]
Weber, B.; Schuster, S.; Zysset, D.; Rihs, S.; Dickgreber, N.; Schürch, C.; Riether, C.; Siegrist, M.; Schneider, C.; Pawelski, H.; et al.
TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 2014, 10, e1003900.
[CrossRef] [PubMed]
Bouchon, A.; Dietrich, J.; Colonna, M. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor
Expressed on Neutrophils and Monocytes. J. Immunol. 2000, 164, 4991–4995. [CrossRef]
Colonna, M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003, 3, 445–453. [CrossRef] [PubMed]
Bouchon, A.; Facchetti, F.; Weigand, M.A.; Colonna, M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock.
Nature 2001, 410, 1103–1107. [CrossRef]
Microbiol. Res. 2021, 12
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
777
Klesney-tait, J.; Turnbull, I.R.; Colonna, M. The TREM receptor family and signal integration. Nat. Immunol. 2006, 7, 1266–1273.
[CrossRef]
Carneiro, M.W.; Fukutani, K.F.; Andrade, B.B.; Curvelo, R.P.; Cristal, J.R.; Carvalho, A.M.; Barral, A.; Van Weyenbergh, J.;
Barral-Netto, M.; de Oliveira, C.I. Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis
Identifies Genes Associated with Cutaneous Leishmaniasis. PLoS Negl. Trop. Dis. 2016, 10, e0005116. [CrossRef]
Nunes, S.; Silva, I.B.; Ampuero, M.R.; de Noronha, A.L.L.; de Souza, L.C.L.; Correia, T.C.; Khouri, R.; Boaventura, V.S.; Barral, A.;
Ramos, P.I.P.; et al. Integrated analysis reveals that miR-193b, miR-671, and TREM-1 correlate with a good response to treatment
of human Localized cutaneous leishmaniasis caused by Leishmania braziliensis. Front. Immunol. 2018, 9, 640. [CrossRef] [PubMed]
Bomfim, L.G.S.; Magalhães, L.S.; Santos-Filho, M.A.A.; Peres, N.T.A.; Corrêa, C.B.; Tanajura, D.M.; Silva, A.M.; Lipscomb, M.W.;
Borges, V.M.; Jesus, A.R.; et al. Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis. Front. Microbiol.
2017, 8, 2265. [CrossRef] [PubMed]
Scorza, B.M.; Wacker, M.A.; Messingham, K.; Kim, P.; Klingelhutz, A.; Fairley, J.; Wilson, M.E. Differential Activation of Human
Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease. J. Invest. Dermatol. 2017, 137, 2149–2156.
[CrossRef] [PubMed]
Rogers, M.; Kropf, P.; Choi, B.S.; Dillon, R.; Podinovskaia, M.; Bates, P.; Müller, I. Proteophosophoglycans regurgitated by
Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog.
2009, 5, e1000555. [CrossRef]
Pivarcsi, A.; Kemény, L.; Dobozy, A. Innate immune functions of the keratinocytes: A review. Acta Microbiol. Immunol. Hung.
2004, 51, 303–310. [CrossRef]
Ehrchen, J.M.; Roebrock, K.; Foell, D.; Nippe, N.; Von Stebut, E.; Johannes, M.; Viemann, D.; Varga, G.; Mu, C.; Schuberth, J.; et al.
Keratinocytes Determine Th1 Immunity during Early Experimental Leishmaniasis. PLoS Pathog. 2010, 6, e1000871. [CrossRef]
Novais, F.O.; Carvalho, L.P.; Passos, S.; Roos, D.S.; Carvalho, E.M.; Scott, P.; Beiting, D.P. Genomic Profiling of Human Leishmania
braziliensis Lesions Identifies Transcriptional Modules Associated with Cutaneous Immunopathology. J. Investig. Dermatol. 2015,
135, 94–101. [CrossRef]
Oliveira, P.R.S.; Dessein, H.; Romano, A.; Cabantous, S.; De Brito, M.E.F.; Santoro, F.; Pitta, M.G.R.; Pereira, V.; Lain, C.;
Rodrigues, V.; et al. IL2RA Genetic Variants Reduce IL-2—Dependent Responses and Aggravate Human Cutaneous Leishmaniasis. J. Immunol. 2015, 194, 2664–2672. [CrossRef]
Ulusan, Ö.; Mert, U.; Sadıqova, A.; Öztürk, S.; Caner, A. Identification of gene expression profiles in Leishmania major infection
by integrated bioinformatics analyses. Acta Trop. 2020, 208, 105517. [CrossRef]
Maiese, A.; Bolino, G.; Mastracchio, A.; Frati, P.; Fineschi, V. An immunohistochemical study of the diagnostic value of TREM-1
as marker for fatal sepsis cases. Biotech. Histochem. 2019, 94, 159–166. [CrossRef]
Fontana, R.; Raccosta, L.; Rovati, L.; Steffensen, K.R.; Jakobsson, T.; Melloni, G.; Bandiera, A.; Bergamini, A.; Maggioni, D.;
Doglioni, C.; et al. Nuclear receptor ligands induce TREM-1 expression on dendritic cells: Analysis of their role in tumors.
Oncoimmunology 2019, 8, 1554967. [CrossRef]
Amrun, S.N.; Tan, J.J.L.; Rickett, N.Y.; Cox, J.A.; Lee, B.; Michael, J.G.; Solomon, T.; Perera, D.; Ooi, M.H.; Hiscox, J.A.; et al.
TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection. Sci. Rep. 2020, 10,
3810. [CrossRef]
Pedro, V.; Neto, S.; De Carvalho, J.C.S.; Pimentel, V.E. Prognostic value of sTREM-1 in COVID-19 patients: A biomarker for
disease severity and mortality. medRxiv 2020. [CrossRef]
Tammaro, A.; Derive, M.; Gibot, S.; Leemans, J.C.; Florquin, S.; Dessing, M.C. TREM-1 and its potential ligands in non-infectious
diseases: From biology to clinical perspectives. Pharmacol. Ther. 2017, 177, 81–95. [CrossRef]
Adukpo, S.; Gyan, B.A.; Ofori, M.F.; Dodoo, D.; Velavan, T.P.; Meyer, C.G. Triggering receptor expressed on myeloid cells 1
(TREM-1) and cytokine gene variants in complicated and uncomplicated malaria. Trop. Med. Int. Health 2016, 21, 1592–1601.
[CrossRef] [PubMed]
Zhang, Y.; He, J.; Zheng, H.; Huang, S.; Lu, F. Association of TREM-1, IL-1β, IL-33/ST2, and TLR Expressions with the
Pathogenesis of Ocular Toxoplasmosis in Mouse Models on Different Genetic Backgrounds. Front. Microbiol. 2019, 10, 2264.
[CrossRef] [PubMed]
Cheng, P.C.; Lin, C.N.; Chen, Y.J.; Chang, F.S.; Tsaihong, J.C.; Lee, K.M. Triggering receptor expressed on myeloid cells (TREM)-1
participates in Schistosoma mansoni inflammatory responses. Parasite Immunol. 2011, 33, 276–286. [CrossRef]
Erdman, L.K.; Dhabangi, A.; Musoke, C.; Conroy, A.L.; Hawkes, M.; Higgins, S.; Rajwans, N.; Wolofsky, K.T.; Streiner, D.L.;
Liles, W.C.; et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: A retrospective case-control study. PLoS ONE 2011, 6, e17440. [CrossRef]
Matejuk, A. Skin Immunity. Arch. Immunol. Ther. Exp. 2017, 66, 45–54. [CrossRef] [PubMed]
Tsepkolenko, A.; Tsepkolenko, V.; Dash, S.; Mishra, A.; Bader, A.; Melerzanov, A.; Giri, S. The regenerative potential of skin and
the immune system. Clin. Cosmet. Investig. Dermatol. 2019, 12, 519–532. [CrossRef] [PubMed]
Santiago-Téllez, A.; Castrillón-Rivera, L.E.; Palma-Ramos, A.; Bello-López, J.M.; Sainz-Espuñes, T.; Contreras-Paredes, A.;
Luna-Herrera, J.; Castañeda-Sánchez, J.I. Keratinocyte infection by Actinomadura madurae triggers an inflammatory response.
Trans. R. Soc. Trop. Med. Hyg. 2019, 113, 392–398. [CrossRef]
Microbiol. Res. 2021, 12
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
778
Koike, S.; Yamasaki, K. Melanogenesis connection with innate immunity and toll-like receptors. Int. J. Mol. Sci. 2020, 21, 9769.
[CrossRef]
Shimada-Omori, R.; Yamasaki, K.; Koike, S.; Yamauchi, T.; Aiba, S. TLR3 augments glucocorticoid-synthetic enzymes expression
in epidermal keratinocytes; Implications of glucocorticoid metabolism in rosacea epidermis. J. Dermatol. Sci. 2020, 100, 58–66.
[CrossRef]
Altonsy, M.O.; Kurwa, H.A.; Lauzon, G.J.; Amrein, M.; Gerber, A.N.; Almishri, W.; Mydlarski, P.R. Corynebacterium tuberculostearicum, a human skin colonizer, induces the canonical nuclear factor-κB inflammatory signaling pathway in human skin
cells. Immunity, Inflamm. Dis. 2020, 8, 62–79. [CrossRef]
Sánchez Luquez, K.Y.; Zerpa, O.; Paz-Villarraga, C.A.; Fernández-Mestre, M. Genetic variability of molecules involved in the
disease pathogenesis in Leishmania infection. Exp. Parasitol. 2020, 218, 108007. [CrossRef]
Regli, I.B.; Passelli, K.; Martínez-Salazar, B.; Amore, J.; Hurrell, B.P.; Müller, A.J.; Tacchini-Cottier, F. TLR7 Sensing by Neutrophils
Is Critical for the Control of Cutaneous Leishmaniasis. Cell Rep. 2020, 31, 107746. [CrossRef] [PubMed]
Tavares, N.M.; Araújo-Santos, T.; Afonso, L.; Nogueira, P.M.; Lopes, U.G.; Soares, R.P.; Bozza, P.T.; Bandeira-Melo, C.; Borges, V.M.;
Brodskyn, C. Understanding the Mechanisms Controlling Leishmania amazonensis Infection In Vitro: The Role of LTB4 Derived
From Human Neutrophils. J. Infect. Dis. 2014, 210, 656–666. [CrossRef]
Tessarz, A.S.; Cerwenka, A. The TREM-1/DAP12 pathway. Immunol. Lett. 2008, 116, 111–116. [CrossRef] [PubMed]
Zeng, H.; Ornatowska, M.; Joo, M.S.; Sadikot, R.T. TREM-1 expression in macrophages is regulated at transcriptional level by
NF-κB and PU.1. Eur. J. Immunol. 2007, 37, 2300–2308. [CrossRef]
Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3, 710–720. [CrossRef] [PubMed]
Arts, R.J.W.; Joosten, L.A.B.; Van Der Meer, J.W.M.; Netea, M.G. TREM-1: Intracellular signaling pathways and interaction with
pattern recognition receptors. J. Leukoc. Biol. 2013, 93, 209–215. [CrossRef] [PubMed]
Prado-Montes de Oca, E. Human β-defensin 1: A restless warrior against allergies, infections and cancer. Int. J. Biochem. Cell Biol.
2010, 42, 800–804. [CrossRef] [PubMed]
Wilmes, M.; Sahl, H.G. Defensin-based anti-infective strategies. Int. J. Med. Microbiol. 2014, 304, 93–99. [CrossRef] [PubMed]